BIRD FLU ROUND UP – TAMIFLU EMEA – EUROPEANPARLIAMENT CALL
December 1st, 2005
BY KEITH NUTHALL
THE EUROPEAN Medicines Evaluation Agency (EMEA) has launched a safety review of the drug Tamiflu, seen as the front-line defence against any bird flu outbreak in humans. It has asked manufacturer Roche to check "all available data on serious psychiatric disorders, including all case reports with a fatal outcome where Tamiflu was involved". This follows a series of reports of psychiatric side-effects, especially in children. Thee have included convulsions, hallucinations, confusion, and bizarre behaviour, for instance, a 12-year-old ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.